News Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-06 pm EDT			5-day change	1st Jan Change
43.5 ^USD	-2.73%		+17.41%	+47.06%

May. 03	Sector Update: Health Care Stocks Mixed in Afternoon Trading	MT
May. 03	Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 03	MT
Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set	May. 03	MT
UBS Adjusts Price Target on Tandem Diabetes Care to $40 From $28, Maintains Neutral Rating	May. 03	MT
Transcript : Tandem Diabetes Care, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (TNDM) TANDEM DIABETES CARE Reports Q1 Revenue $191.7M, vs. Street Est of $173.5M	May. 02	MT
Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance	May. 02	BU
Tandem Diabetes Care, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
North American Morning Briefing : More Earnings -2-	Apr. 30	DJ
Tandem Diabetes Care Announces Upcoming Conference Presentations	Apr. 29	BU
Wells Fargo Upgrades Tandem Diabetes Care to Overweight From Equalweight, Price Target is $45	Apr. 29	MT
North American Morning Briefing : Tech Still in -2-	Apr. 26	DJ
Leerink Partners Upgrades Tandem Diabetes Care to Outperform Rating, Price Target is $45	Apr. 25	MT
Stifel Adjusts Price Target on Tandem Diabetes Care to $40 From $37, Maintains Buy Rating	Apr. 23	MT
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024	Apr. 09	BU
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
Tandem Diabetes Care Shares Rise After Stifel Upgrade	Mar. 26	MT
Stifel Upgrades Tandem Diabetes Care to Buy From Hold, Adjusts Price Target to $37 From $24	Mar. 26	MT
Citigroup Raises Price Target on Tandem Diabetes Care to $31 From $25, Keeps Neutral Rating	Mar. 15	MT
Transcript : Tandem Diabetes Care, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03:35 PM	Mar. 13
Transcript : Tandem Diabetes Care, Inc. Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 01:20 PM	Mar. 12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Summary

Filters